MENU

CNC/Chitosan Nanocrystals: Low-Cost Cancer-Detecting Paper Tests

Bioengineer.org USA
Overview
Researchers have developed a modular paper-based immunoassay platform using a composite of cellulose nanocrystals (CNC) and chitosan nanocrystals (Ch) to detect cancer biomarkers. The composite support reduces variability in antigen-binding responses compared to using either nanocrystal alone, enabling a more reproducible and cost-effective diagnostic tool.
In Depth

Key Findings

The integration of cellulose nanocrystals (CNC) and chitosan nanocrystals (Ch) as a support for antibodies results in less variable antigen-binding responses than individual nanocrystal types. While pure CNCs are mechanically robust, their strongly anionic sulfated surfaces can cause non-specific electrostatic interactions and conformational perturbations in antibodies. Conversely, pure chitosan nanocrystals are subject to pH-dependent charge variability and solubility transitions. Blending these materials mitigates these individual weaknesses to create a more stable capture surface.

Technical Details

The study utilized CEACAM5 (carcinoembryonic antigen/CD66e) as the model analyte due to its clinical relevance in monitoring adenocarcinomas of the colon, pancreas, lung, and breast. To attach antibodies to the nanocrystals, the researchers employed carbodiimide coupling chemistry, using EDC to activate carboxylic acid groups into O-acylisourea intermediates, which NHS then converts into stable NHS esters that react with antibody primary amines.

The interface was analyzed using a complementary suite of techniques:

  • FTIR: Confirmed sulfate ester groups on CNC, amine/amide bands on chitosan, and amide I and II signatures of immunoglobulins.
  • AFM: Verified the preservation of the rod-like morphology of cellulose whiskers.
  • Zeta-potential & DLS: Measured surface charges (negative for CNC, cationic for chitosan) and hydrodynamic diameters in buffered media.
  • QCM-D & SPR: Quartz crystal microbalance with dissipation monitoring and surface plasmon resonance were used in parallel to cross-validate binding kinetics and distinguish between rigid antibody films and hydrated layers.

Background & Context

CEACAM5 is a glycosylated cell-surface glycoprotein used routinely in clinical oncology to monitor treatment response and recurrence in colorectal cancer. Because monoclonal antibodies for CEACAM5 are commercially available and its circulating concentrations span a meaningful range, it serves as a benchmark for evaluating new biosensor architectures.

Significance & Outlook

The modular design of this paper-based platform allows for the detection of different biomarkers simply by swapping the immobilized antibody. By optimizing the density and orientation of antibodies on the CNC/Ch composite, the platform provides a reproducible foundation for cheaper, scalable cancer-detecting tests.

Source: https://bioengineer.org/cotton-and-chitosan-nanocrystals-team-up-for-cheaper-cancer-detecting-paper-tests/

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.

  • Your email and selected fields are used only to deliver the newsletter.
  • We never share your information with third parties.
  • You can unsubscribe anytime via the link in each email.

See our Privacy Policy for details.

Takes about a minute · Unsubscribe anytime

Published by Troy-Technical, an independent site run by one engineer with a career in materials development.
About the author / Contact info@troy-technical.jp
Let's share this post !

Author of this article

TOC